Myeloablative unrelated cord blood transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia: comparison with other graft sources from related and unrelated ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2014-09-03

AUTHORS

Takaaki Konuma, Seiko Kato, Jun Ooi, Maki Oiwa-Monna, Arinobu Tojo, Satoshi Takahashi

ABSTRACT

Philadelphia chromosome (Ph)-positive acute lymphoblastic leukemia (ALL) is a distinct clinical entity among ALL and is associated with adverse outcomes and higher rates of relapse when conventional chemotherapy is used alone. Although allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a potentially curative therapy for patients with Ph+ALL, the impact of graft sources, particularly cord blood transplantation (CBT), on allo-HSCT for patients with Ph+ALL has yet to be clarified. We retrospectively compared clinical outcomes after unrelated CBT (n = 20), unrelated bone marrow transplantation (n = 7), and related bone marrow and peripheral blood stem cell transplantations (n = 13) following myeloablative conditioning in 40 patients with Ph+ALL. Although graft source had no significant impact on survival or relapse, disease status at transplantation did significantly affect outcomes. These data suggest that unrelated CBT is feasible and should be considered early in the course of patients with Ph+ALL when HLA-compatible related and unrelated donors are not available. More... »

PAGES

289-296

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00277-014-2195-9

DOI

http://dx.doi.org/10.1007/s00277-014-2195-9

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1005986147

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/25178518


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bone Marrow Transplantation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cord Blood Stem Cell Transplantation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Feasibility Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Graft vs Host Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hematopoietic Stem Cell Transplantation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Peripheral Blood Stem Cell Transplantation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Philadelphia Chromosome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Precursor Cell Lymphoblastic Leukemia-Lymphoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Reproducibility of Results", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Transplantation Conditioning", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Transplantation, Homologous", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Unrelated Donors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Young Adult", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, 4-6-1, Shirokanedai, 108-8639, Tokyo, Minato-ku, Japan", 
          "id": "http://www.grid.ac/institutes/grid.26999.3d", 
          "name": [
            "Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, 4-6-1, Shirokanedai, 108-8639, Tokyo, Minato-ku, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Konuma", 
        "givenName": "Takaaki", 
        "id": "sg:person.01350075427.97", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01350075427.97"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, 4-6-1, Shirokanedai, 108-8639, Tokyo, Minato-ku, Japan", 
          "id": "http://www.grid.ac/institutes/grid.26999.3d", 
          "name": [
            "Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, 4-6-1, Shirokanedai, 108-8639, Tokyo, Minato-ku, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kato", 
        "givenName": "Seiko", 
        "id": "sg:person.015266563712.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015266563712.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology/Oncology, Teikyo University School of Medicine, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.264706.1", 
          "name": [
            "Department of Hematology/Oncology, Teikyo University School of Medicine, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ooi", 
        "givenName": "Jun", 
        "id": "sg:person.01336264132.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01336264132.00"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, 4-6-1, Shirokanedai, 108-8639, Tokyo, Minato-ku, Japan", 
          "id": "http://www.grid.ac/institutes/grid.26999.3d", 
          "name": [
            "Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, 4-6-1, Shirokanedai, 108-8639, Tokyo, Minato-ku, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Oiwa-Monna", 
        "givenName": "Maki", 
        "id": "sg:person.01112536643.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01112536643.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, 4-6-1, Shirokanedai, 108-8639, Tokyo, Minato-ku, Japan", 
          "id": "http://www.grid.ac/institutes/grid.26999.3d", 
          "name": [
            "Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, 4-6-1, Shirokanedai, 108-8639, Tokyo, Minato-ku, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tojo", 
        "givenName": "Arinobu", 
        "id": "sg:person.0703364434.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0703364434.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, 4-6-1, Shirokanedai, 108-8639, Tokyo, Minato-ku, Japan", 
          "id": "http://www.grid.ac/institutes/grid.26999.3d", 
          "name": [
            "Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, 4-6-1, Shirokanedai, 108-8639, Tokyo, Minato-ku, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Takahashi", 
        "givenName": "Satoshi", 
        "id": "sg:person.0721047700.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0721047700.17"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/bmt.2008.296", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033326494", 
          "https://doi.org/10.1038/bmt.2008.296"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bmt.2008.347", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006145864", 
          "https://doi.org/10.1038/bmt.2008.347"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/leu.2010.228", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018775968", 
          "https://doi.org/10.1038/leu.2010.228"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bmt.2009.283", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053212008", 
          "https://doi.org/10.1038/bmt.2009.283"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bmt.1705148", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042474890", 
          "https://doi.org/10.1038/sj.bmt.1705148"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/leu.2012.352", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021091201", 
          "https://doi.org/10.1038/leu.2012.352"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bmt.2012.244", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028358194", 
          "https://doi.org/10.1038/bmt.2012.244"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/leu.2013.253", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021658729", 
          "https://doi.org/10.1038/leu.2013.253"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2014-09-03", 
    "datePublishedReg": "2014-09-03", 
    "description": "Philadelphia chromosome (Ph)-positive acute lymphoblastic leukemia (ALL) is a distinct clinical entity among ALL and is associated with adverse outcomes and higher rates of relapse when conventional chemotherapy is used alone. Although allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a potentially curative therapy for patients with Ph+ALL, the impact of graft sources, particularly cord blood transplantation (CBT), on allo-HSCT for patients with Ph+ALL has yet to be clarified. We retrospectively compared clinical outcomes after unrelated CBT (n\u2009=\u200920), unrelated bone marrow transplantation (n\u2009=\u20097), and related bone marrow and peripheral blood stem cell transplantations (n\u2009=\u200913) following myeloablative conditioning in 40 patients with Ph+ALL. Although graft source had no significant impact on survival or relapse, disease status at transplantation did significantly affect outcomes. These data suggest that unrelated CBT is feasible and should be considered early in the course of patients with Ph+ALL when HLA-compatible related and unrelated donors are not available.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00277-014-2195-9", 
    "isAccessibleForFree": false, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.6126539", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1358129", 
        "issn": [
          "0939-5555", 
          "1432-0584"
        ], 
        "name": "Annals of Hematology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "94"
      }
    ], 
    "keywords": [
      "acute lymphoblastic leukemia", 
      "stem cell transplantation", 
      "graft source", 
      "unrelated CBT", 
      "blood transplantation", 
      "unrelated donors", 
      "cell transplantation", 
      "lymphoblastic leukemia", 
      "myeloablative unrelated cord blood transplantation", 
      "peripheral blood stem cell transplantation", 
      "allogeneic hematopoietic stem cell transplantation", 
      "Philadelphia chromosome-positive acute lymphoblastic leukemia", 
      "unrelated cord blood transplantation", 
      "blood stem cell transplantation", 
      "unrelated bone marrow transplantation", 
      "hematopoietic stem cell transplantation", 
      "positive acute lymphoblastic leukemia", 
      "cord blood transplantation", 
      "course of patients", 
      "bone marrow transplantation", 
      "distinct clinical entity", 
      "allo-HSCT", 
      "myeloablative conditioning", 
      "curative therapy", 
      "clinical outcomes", 
      "marrow transplantation", 
      "clinical entity", 
      "adverse outcomes", 
      "conventional chemotherapy", 
      "transplantation", 
      "bone marrow", 
      "Philadelphia chromosome", 
      "disease status", 
      "patients", 
      "relapse", 
      "outcomes", 
      "leukemia", 
      "high rate", 
      "CBT", 
      "chemotherapy", 
      "HLA", 
      "therapy", 
      "marrow", 
      "donors", 
      "survival", 
      "status", 
      "course", 
      "significant impact", 
      "entities", 
      "rate", 
      "impact", 
      "conditioning", 
      "data", 
      "comparison", 
      "source", 
      "chromosomes"
    ], 
    "name": "Myeloablative unrelated cord blood transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia: comparison with other graft sources from related and unrelated donors", 
    "pagination": "289-296", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1005986147"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00277-014-2195-9"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "25178518"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00277-014-2195-9", 
      "https://app.dimensions.ai/details/publication/pub.1005986147"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-08-04T17:01", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/article/article_638.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00277-014-2195-9"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00277-014-2195-9'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00277-014-2195-9'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00277-014-2195-9'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00277-014-2195-9'


 

This table displays all metadata directly associated to this object as RDF triples.

281 TRIPLES      21 PREDICATES      112 URIs      96 LITERALS      30 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00277-014-2195-9 schema:about N0ce6bd06c2a94484b87630433accace0
2 N127afb58065b4c72b36b0922dd28da3d
3 N2460a2e4a0cd46849133ce539c240b48
4 N397fbec125764cdea7a57521c4a26966
5 N468e69b8cf2b4ab39d4239ba2b97a7ce
6 N48f8cc6532174ba5b150b130031d787d
7 N5fd0f84101d54c46932c802b1415b9fc
8 N6e5224d80a5340fc85b646548039ce19
9 N6f1e9988bab04602b43052909100ef37
10 N70d45dcc338c4a9fb61a0251c84c20b3
11 N854ee64a386c4f278f608424e805f411
12 N9ed069bfcbb346128acdbcffa7f43601
13 N9f464815f1a24c1f8b05f7bf9ac73a20
14 Na5f041b4225748e4af4437a625702576
15 Nb21fd323f2564c16a3aabbb66020792a
16 Nb28c9e3a4b72477d942c55621786a962
17 Nc21c76c33c61426aaaf8bd16223da414
18 Nc9850274ebe04b55995a7ef25597c441
19 Ndabbc596722f4627942efe57ccfa610d
20 Ne0bb43aea5d440cdbdd2eb3a8e03b342
21 Ne74d29dfbbd047d8ad7c0f8b7283b4ec
22 Ned1f2f23970949e29e8b13f1c83439c6
23 Nfec43af967844ac59c119607418be6fa
24 anzsrc-for:11
25 anzsrc-for:1102
26 schema:author Nbaacc37e138645feb664a465e7c1ee6b
27 schema:citation sg:pub.10.1038/bmt.2008.296
28 sg:pub.10.1038/bmt.2008.347
29 sg:pub.10.1038/bmt.2009.283
30 sg:pub.10.1038/bmt.2012.244
31 sg:pub.10.1038/leu.2010.228
32 sg:pub.10.1038/leu.2012.352
33 sg:pub.10.1038/leu.2013.253
34 sg:pub.10.1038/sj.bmt.1705148
35 schema:datePublished 2014-09-03
36 schema:datePublishedReg 2014-09-03
37 schema:description Philadelphia chromosome (Ph)-positive acute lymphoblastic leukemia (ALL) is a distinct clinical entity among ALL and is associated with adverse outcomes and higher rates of relapse when conventional chemotherapy is used alone. Although allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a potentially curative therapy for patients with Ph+ALL, the impact of graft sources, particularly cord blood transplantation (CBT), on allo-HSCT for patients with Ph+ALL has yet to be clarified. We retrospectively compared clinical outcomes after unrelated CBT (n = 20), unrelated bone marrow transplantation (n = 7), and related bone marrow and peripheral blood stem cell transplantations (n = 13) following myeloablative conditioning in 40 patients with Ph+ALL. Although graft source had no significant impact on survival or relapse, disease status at transplantation did significantly affect outcomes. These data suggest that unrelated CBT is feasible and should be considered early in the course of patients with Ph+ALL when HLA-compatible related and unrelated donors are not available.
38 schema:genre article
39 schema:isAccessibleForFree false
40 schema:isPartOf N99597fc0e54c4b77a168c9b634c5a1d7
41 Nedf2a0283f1347e680b7ba050af843ed
42 sg:journal.1358129
43 schema:keywords CBT
44 HLA
45 Philadelphia chromosome
46 Philadelphia chromosome-positive acute lymphoblastic leukemia
47 acute lymphoblastic leukemia
48 adverse outcomes
49 allo-HSCT
50 allogeneic hematopoietic stem cell transplantation
51 blood stem cell transplantation
52 blood transplantation
53 bone marrow
54 bone marrow transplantation
55 cell transplantation
56 chemotherapy
57 chromosomes
58 clinical entity
59 clinical outcomes
60 comparison
61 conditioning
62 conventional chemotherapy
63 cord blood transplantation
64 course
65 course of patients
66 curative therapy
67 data
68 disease status
69 distinct clinical entity
70 donors
71 entities
72 graft source
73 hematopoietic stem cell transplantation
74 high rate
75 impact
76 leukemia
77 lymphoblastic leukemia
78 marrow
79 marrow transplantation
80 myeloablative conditioning
81 myeloablative unrelated cord blood transplantation
82 outcomes
83 patients
84 peripheral blood stem cell transplantation
85 positive acute lymphoblastic leukemia
86 rate
87 relapse
88 significant impact
89 source
90 status
91 stem cell transplantation
92 survival
93 therapy
94 transplantation
95 unrelated CBT
96 unrelated bone marrow transplantation
97 unrelated cord blood transplantation
98 unrelated donors
99 schema:name Myeloablative unrelated cord blood transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia: comparison with other graft sources from related and unrelated donors
100 schema:pagination 289-296
101 schema:productId N28f6e24661f44e69bca05af2b961e111
102 N7dade2aa40e4439290fd3c10a222584a
103 N886e08c44b964491a14c70ae56bc175b
104 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005986147
105 https://doi.org/10.1007/s00277-014-2195-9
106 schema:sdDatePublished 2022-08-04T17:01
107 schema:sdLicense https://scigraph.springernature.com/explorer/license/
108 schema:sdPublisher Nae3f9bccfd3d47a39ca8911c6b3dc7b8
109 schema:url https://doi.org/10.1007/s00277-014-2195-9
110 sgo:license sg:explorer/license/
111 sgo:sdDataset articles
112 rdf:type schema:ScholarlyArticle
113 N0ce6bd06c2a94484b87630433accace0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Middle Aged
115 rdf:type schema:DefinedTerm
116 N127afb58065b4c72b36b0922dd28da3d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Hematopoietic Stem Cell Transplantation
118 rdf:type schema:DefinedTerm
119 N2460a2e4a0cd46849133ce539c240b48 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Young Adult
121 rdf:type schema:DefinedTerm
122 N28f6e24661f44e69bca05af2b961e111 schema:name pubmed_id
123 schema:value 25178518
124 rdf:type schema:PropertyValue
125 N3279c3c9c48a4b1ba69e23e955f7463d rdf:first sg:person.015266563712.53
126 rdf:rest N91ce633fc3d745a5a3ecaca71cf6d269
127 N397fbec125764cdea7a57521c4a26966 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Unrelated Donors
129 rdf:type schema:DefinedTerm
130 N468e69b8cf2b4ab39d4239ba2b97a7ce schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Adult
132 rdf:type schema:DefinedTerm
133 N48f8cc6532174ba5b150b130031d787d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Precursor Cell Lymphoblastic Leukemia-Lymphoma
135 rdf:type schema:DefinedTerm
136 N5a52133fe3f34908b7678a4b1d97ffc3 rdf:first sg:person.0721047700.17
137 rdf:rest rdf:nil
138 N5fd0f84101d54c46932c802b1415b9fc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Bone Marrow Transplantation
140 rdf:type schema:DefinedTerm
141 N6e5224d80a5340fc85b646548039ce19 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Transplantation Conditioning
143 rdf:type schema:DefinedTerm
144 N6f1e9988bab04602b43052909100ef37 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Female
146 rdf:type schema:DefinedTerm
147 N70d45dcc338c4a9fb61a0251c84c20b3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Retrospective Studies
149 rdf:type schema:DefinedTerm
150 N7dade2aa40e4439290fd3c10a222584a schema:name dimensions_id
151 schema:value pub.1005986147
152 rdf:type schema:PropertyValue
153 N854ee64a386c4f278f608424e805f411 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Male
155 rdf:type schema:DefinedTerm
156 N886e08c44b964491a14c70ae56bc175b schema:name doi
157 schema:value 10.1007/s00277-014-2195-9
158 rdf:type schema:PropertyValue
159 N91ce633fc3d745a5a3ecaca71cf6d269 rdf:first sg:person.01336264132.00
160 rdf:rest Nc1a926b570e44eeca24fcd132db16646
161 N99597fc0e54c4b77a168c9b634c5a1d7 schema:volumeNumber 94
162 rdf:type schema:PublicationVolume
163 N9ed069bfcbb346128acdbcffa7f43601 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Adolescent
165 rdf:type schema:DefinedTerm
166 N9f464815f1a24c1f8b05f7bf9ac73a20 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Treatment Outcome
168 rdf:type schema:DefinedTerm
169 Na5f041b4225748e4af4437a625702576 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Cord Blood Stem Cell Transplantation
171 rdf:type schema:DefinedTerm
172 Nae3f9bccfd3d47a39ca8911c6b3dc7b8 schema:name Springer Nature - SN SciGraph project
173 rdf:type schema:Organization
174 Nb21fd323f2564c16a3aabbb66020792a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
175 schema:name Survival Analysis
176 rdf:type schema:DefinedTerm
177 Nb28c9e3a4b72477d942c55621786a962 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
178 schema:name Graft vs Host Disease
179 rdf:type schema:DefinedTerm
180 Nbaacc37e138645feb664a465e7c1ee6b rdf:first sg:person.01350075427.97
181 rdf:rest N3279c3c9c48a4b1ba69e23e955f7463d
182 Nc1a926b570e44eeca24fcd132db16646 rdf:first sg:person.01112536643.08
183 rdf:rest Nf13cfabf6a6a48fd957a448415357235
184 Nc21c76c33c61426aaaf8bd16223da414 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
185 schema:name Transplantation, Homologous
186 rdf:type schema:DefinedTerm
187 Nc9850274ebe04b55995a7ef25597c441 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
188 schema:name Feasibility Studies
189 rdf:type schema:DefinedTerm
190 Ndabbc596722f4627942efe57ccfa610d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
191 schema:name Child
192 rdf:type schema:DefinedTerm
193 Ne0bb43aea5d440cdbdd2eb3a8e03b342 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
194 schema:name Philadelphia Chromosome
195 rdf:type schema:DefinedTerm
196 Ne74d29dfbbd047d8ad7c0f8b7283b4ec schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
197 schema:name Humans
198 rdf:type schema:DefinedTerm
199 Ned1f2f23970949e29e8b13f1c83439c6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
200 schema:name Peripheral Blood Stem Cell Transplantation
201 rdf:type schema:DefinedTerm
202 Nedf2a0283f1347e680b7ba050af843ed schema:issueNumber 2
203 rdf:type schema:PublicationIssue
204 Nf13cfabf6a6a48fd957a448415357235 rdf:first sg:person.0703364434.08
205 rdf:rest N5a52133fe3f34908b7678a4b1d97ffc3
206 Nfec43af967844ac59c119607418be6fa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
207 schema:name Reproducibility of Results
208 rdf:type schema:DefinedTerm
209 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
210 schema:name Medical and Health Sciences
211 rdf:type schema:DefinedTerm
212 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
213 schema:name Cardiorespiratory Medicine and Haematology
214 rdf:type schema:DefinedTerm
215 sg:grant.6126539 http://pending.schema.org/fundedItem sg:pub.10.1007/s00277-014-2195-9
216 rdf:type schema:MonetaryGrant
217 sg:journal.1358129 schema:issn 0939-5555
218 1432-0584
219 schema:name Annals of Hematology
220 schema:publisher Springer Nature
221 rdf:type schema:Periodical
222 sg:person.01112536643.08 schema:affiliation grid-institutes:grid.26999.3d
223 schema:familyName Oiwa-Monna
224 schema:givenName Maki
225 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01112536643.08
226 rdf:type schema:Person
227 sg:person.01336264132.00 schema:affiliation grid-institutes:grid.264706.1
228 schema:familyName Ooi
229 schema:givenName Jun
230 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01336264132.00
231 rdf:type schema:Person
232 sg:person.01350075427.97 schema:affiliation grid-institutes:grid.26999.3d
233 schema:familyName Konuma
234 schema:givenName Takaaki
235 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01350075427.97
236 rdf:type schema:Person
237 sg:person.015266563712.53 schema:affiliation grid-institutes:grid.26999.3d
238 schema:familyName Kato
239 schema:givenName Seiko
240 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015266563712.53
241 rdf:type schema:Person
242 sg:person.0703364434.08 schema:affiliation grid-institutes:grid.26999.3d
243 schema:familyName Tojo
244 schema:givenName Arinobu
245 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0703364434.08
246 rdf:type schema:Person
247 sg:person.0721047700.17 schema:affiliation grid-institutes:grid.26999.3d
248 schema:familyName Takahashi
249 schema:givenName Satoshi
250 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0721047700.17
251 rdf:type schema:Person
252 sg:pub.10.1038/bmt.2008.296 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033326494
253 https://doi.org/10.1038/bmt.2008.296
254 rdf:type schema:CreativeWork
255 sg:pub.10.1038/bmt.2008.347 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006145864
256 https://doi.org/10.1038/bmt.2008.347
257 rdf:type schema:CreativeWork
258 sg:pub.10.1038/bmt.2009.283 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053212008
259 https://doi.org/10.1038/bmt.2009.283
260 rdf:type schema:CreativeWork
261 sg:pub.10.1038/bmt.2012.244 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028358194
262 https://doi.org/10.1038/bmt.2012.244
263 rdf:type schema:CreativeWork
264 sg:pub.10.1038/leu.2010.228 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018775968
265 https://doi.org/10.1038/leu.2010.228
266 rdf:type schema:CreativeWork
267 sg:pub.10.1038/leu.2012.352 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021091201
268 https://doi.org/10.1038/leu.2012.352
269 rdf:type schema:CreativeWork
270 sg:pub.10.1038/leu.2013.253 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021658729
271 https://doi.org/10.1038/leu.2013.253
272 rdf:type schema:CreativeWork
273 sg:pub.10.1038/sj.bmt.1705148 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042474890
274 https://doi.org/10.1038/sj.bmt.1705148
275 rdf:type schema:CreativeWork
276 grid-institutes:grid.264706.1 schema:alternateName Department of Hematology/Oncology, Teikyo University School of Medicine, Tokyo, Japan
277 schema:name Department of Hematology/Oncology, Teikyo University School of Medicine, Tokyo, Japan
278 rdf:type schema:Organization
279 grid-institutes:grid.26999.3d schema:alternateName Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, 4-6-1, Shirokanedai, 108-8639, Tokyo, Minato-ku, Japan
280 schema:name Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, 4-6-1, Shirokanedai, 108-8639, Tokyo, Minato-ku, Japan
281 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...